Geode Capital Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $13.6K | Hold |
|
|||||
|
2023
Q3 | $22.2K | Buy |
|
|||||
|
2023
Q2 | $15.2K | Hold |
|
|||||
|
2023
Q1 | $11.8K | Hold |
|
|||||
|
2022
Q4 | $26K | Hold |
|
|||||
|
2022
Q3 | $47K | Buy |
|
|||||
|
2022
Q2 | $44K | Buy |
|
|||||
|
2022
Q1 | $95K | Hold |
|
|||||
|
2021
Q4 | $126K | Hold |
|
|||||
|
2021
Q3 | $192K | Hold |
|
|||||
|
2021
Q2 | $205K | Buy |
|
|||||
|
2021
Q1 | $185K | Buy |
|
|||||
|
2020
Q4 | $35K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2K | Hold |
|
|||||
|
2019
Q3 | $5K | Hold |
|
|||||
|
2019
Q2 | $7K | Hold |
|
|||||
|
2019
Q1 | $15K | Hold |
|
|||||
|
2018
Q4 | $15K | Hold |
|
|||||
|
2018
Q3 | $20K | Hold |
|
|||||
|
2018
Q2 | $17K | Buy |
|
|||||
|
2018
Q1 | $93K | Hold |
|
|||||
|
2017
Q4 | $133K | Sell |
|
|||||
|
2017
Q3 | $265K | Hold |
|
|||||
|
2017
Q2 | $485K | Sell |
|
|||||
|
2017
Q1 | $956K | Buy |
|
|||||
|
2016
Q4 | $960K | Hold |
|
|||||
|
2016
Q3 | $1.48M | Buy |
|
|||||
|
2016
Q2 | $1.16M | Hold |
|
|||||
|
2016
Q1 | $1.39K | Buy |
|
|||||
|
2015
Q4 | $1.2M | Hold |
|
|||||
|
2015
Q3 | $1.43M | Buy |
|